Business Wire

700 Songs “IPO” in a Day as Music Financial Exchange Sonomo Opens to Public

Share

Music investment platform Sonomo (sonomo.com) announces its opening to the public. The platform is democratizing access to music investing, a $1 trillion asset class previously dominated by industry insiders and speciality funds.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230711288235/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Sonomo's investor dashboard (Graphic: Business Wire)

Since its public opening, the Amsterdam-based company has witnessed an extraordinary response from investors worldwide. In a single day, the platform hosted an astonishing 700 song "Initial Public Offerings" (IPOs), solidifying its position as the world's largest public exchange for music as an asset-class.

Through Sonomo, investors are able to trade “fractionalized shares'' in thousands of songs and ETF-like “Baskets”. The platform prides itself in catering to a wide range of genres and artists. Investors can access both new, more speculative songs, and timeless classics by artists such as Gloria Gaynor, Barbara Mason, and Edwin Starr.

Sonomo collects royalties from over a hundred streaming platforms. Such royalties are then distributed to shareholders on a monthly basis. Sonomo empowers investors to correctly price assets by providing real-time data feeds relating to how songs are performing on streaming platforms (daily streaming analytics, historic earnings and so on). External market-makers operate on the platform, injecting liquidity into assets.

This marks a significant shift in alternative investing. You’re now able to trade song shares in real-time on a 1% brokerage fee and collect monthly ‘royalty dividends’ - a fraction of the cost and time of private equity alternatives.”, “Investors are seeking income-generating assets that perform in an inflationary environment. At the same time, artists are opting for independently financed careers at an unprecedented rate. We want to facilitate that transition for both.Faris Zaher, CEO of Sonomo.

ENDS

About Sonomo

Sonomo is a financial exchange on a mission to democratize music financing. The platform’s automated securitization pipeline can turn any song into an investable asset. For more information about Sonomo, please visit sonomo.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Faris Zaher
press@sonomo.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Dubai Brings Together Sport Stars and Legends, Leaders and Decision-Makers on the Largest Global Platform to Shape the Future of Sports: the World Sports Summit18.12.2025 15:40:00 EET | Press release

The Dubai Sports Council has announced the launch of the World Sports Summit (WSS), which will take place under the directives of His Highness Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, Crown Prince of Dubai, Deputy Prime Minister, Minister of Defence and Chairman of the Executive Council of Dubai. The event is set to be held from December 29-30, 2025 at Madinat Jumeirah in Dubai, under the theme ‘Uniting the World Through Sports’. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218607571/en/ Dubai Brings Together Sport Stars and Legends, Leaders and Decision-Makers on the Largest Global Platform to Shape the Future of Sports: the World Sports Summit (Photo: AETOSWire) The Summit will be the largest global gathering of its kind, bringing together a distinguished group of top sports decision-makers, experts, global stars, representatives of international sports federations and organisations, investors and innovators

Regula Wins High Customer Marks and Strong Momentum in G2’s Winter 2026 Grid Reports for Identity Verification18.12.2025 15:11:00 EET | Press release

Regula, a global developer of identity verification solutions, has been recognized by customers on G2’s review platform as one of the fastest-rising and most trusted vendors in the identity verification market. Regula is named as a Leader in three G2 Winter 2026 Grid® Reports for Identity Verification. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218134153/en/ Regula is recognized as a Leader in G2’s Winter 2026 Grid Reports for Identity Verification, reflecting strong customer satisfaction and enterprise-grade IDV capabilities. This season, Regula earned a Leader placement in G2’s Overall Grid® for Identity Verification Software, reflecting strong customer satisfaction and a growing presence in the market. The company was also named a Leader in the Momentum Grid® Report for Identity Verification, highlighting accelerating demand for Regula’s solutions and increasingly positive feedback from users. In addition, Regula a

Aptiv and Vecna Robotics to Develop Next Generation Autonomous Mobile Robots18.12.2025 15:00:00 EET | Press release

Aptiv PLC (NYSE: APTV), a global industrial technology leader, and Vecna Robotics, a pioneer in AI-driven autonomous material handling solutions, today announced a strategic collaboration to co-develop next-generation Autonomous Mobile Robot (AMR) solutions designed to deliver cost-efficient automation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218958100/en/ Aptiv’s advanced perception portfolio and machine learning technologies will be integrated into Vecna Robotics’ platform. This partnership combines Aptiv’s industry-leading portfolio, with Vecna Robotics’ advanced autonomy and orchestration platform to provide safer, more efficient, and scalable material handling systems. “Automation is transforming the way goods move through warehouses and factories, with devices that sense, think and act in real time,” said Javed Khan, Executive Vice President, Intelligent Systems, Aptiv. “Our collaboration with Vecna Robotics

Syremis Therapeutics Launches with $165M to Develop Best-in-Class Medicines for Mental Health Conditions18.12.2025 15:00:00 EET | Press release

Syremis Therapeutics, a clinical-stage biopharmaceutical company developing novel medicines to make a profound impact on the treatment of mental health, today announced its launch with a $165 million financing. The Series A, co-led by Dexcel Pharma and Third Rock Ventures, with participation from Bain Capital Life Sciences, GV (Google Ventures), QVT, and Pictet will support the advancement of Syremis’ pipeline through clinical proof of concept. Schizophrenia and other psychotic disorders remain among the most debilitating and underserved conditions worldwide, with more than 20 million people affected and facing considerable disability, elevated relapse rates, and reduced life expectancy. Despite decades of need, current treatments often fall short in both efficacy and tolerability. Syremis’ lead program, ST-905, is a dual M1/M4 muscarinic agonist under development for schizophrenia and other neuropsychiatric conditions and is currently in Phase 1. The molecule’s differentiated potency

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma18.12.2025 13:00:00 EET | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company Fast Track Designation for BGB-B2033, its GPC3x4-1BB bispecific antibody for the treatment of adult patients with hepatocellular carcinoma (HCC) with disease progression on or after prior systemic treatment. “The FDA awards Fast Track Designation to therapies that show potential to address an unmet medical need in serious or life-threatening conditions. The FDA’s decision reflects the encouraging profile of BGB-B2033 in advanced hepatocellular carcinoma, where patients continue to face limited treatment options,” said Julie Lepin, Senior Vice President and Chief Regulatory Affairs Officer at BeOne. BeOne is currently conducting a global, multi-center Phase 1 clinical trial (NCT06427941) to explore the safety and anti-tumor activity of BGB-B2033, both alone and in combination with PD-1 inhibitor TEVIMBRA® (tisle

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye